S. Dudhgaonkar
发表
Jiri Adamec,
George E. Sandusky,
J. Adamec,
2012,
PloS one.
Synergistic interaction between meloxicam and aminoguanidine in formalin‐induced nociception in mice
V. R. Prakash,
S. K. Tandan,
Dinesh Kumar,
2008,
European journal of pain.
Rongan Zhang,
M. Bouvier,
D. Gordon,
2021,
JACC. Basic to translational science.
S. K. Tandan,
M. Kataria,
S. Dudhgaonkar,
2007,
Inflammopharmacology.
K. McIntyre,
Wen-pin Yang,
S. Ruepp,
2017,
The Journal of Immunology.
K. McIntyre,
Wen-pin Yang,
S. Ruepp,
2016
.
M. Srinivasan,
K. Kodumudi,
S. Dudhgaonkar,
2009,
The Journal of Immunology.
J. Simon,
Qingli Wu,
D. Sliva,
2011,
Nutrition journal.
Shana L. Posy,
G. Schieven,
J. Macor,
2022,
ACS medicinal chemistry letters.
Shana L. Posy,
G. Schieven,
M. Poss,
2020,
ACS medicinal chemistry letters.
Dinesh Kumar,
S. Dudhgaonkar,
Sachin H Jadhav,
2006,
Life sciences.
Dinesh Kumar,
S. Dudhgaonkar,
S. Tandan,
2008
.
M. Struthers,
P. Mangan,
C. Tovar,
2021,
The Journal of Immunology.
D. Sliva,
S. Dudhgaonkar,
A. Thyagarajan,
2009,
International immunopharmacology.
V. R. Prakash,
Dinesh Kumar,
M. Kataria,
2006,
European journal of pain.
Dinesh Kumar,
S. Dudhgaonkar,
A. Naik,
2006,
European journal of pharmacology.
Siva Subramani,
S. Dudhgaonkar,
R. Vikramadithyan,
2014,
International immunopharmacology.
G. Sandusky,
D. Sliva,
Jiahua Jiang,
2010,
International journal of molecular medicine.
K. McIntyre,
A. Fura,
K. Gillooly,
2017,
PloS one.
M. Kelley,
D. Sliva,
A. Jedinák,
2011,
Anticancer research.
Michael G. Yang,
D. Shuster,
C. Weigelt,
2021,
ACS medicinal chemistry letters.
D. Sliva,
A. Jedinák,
S. Dudhgaonkar,
2010,
Immunobiology.
B. Srikumar,
R. Pieschl,
L. Bristow,
2018,
Journal of psychopharmacology.
M. Sedlák,
J. Adamec,
A. Jannasch,
2009,
Journal of separation science.
Vivek Jayaswal,
V. Shobha,
A. Mohan,
2021,
Lupus.
Dinesh Kumar,
S. Dudhgaonkar,
A. Naik,
2004,
European journal of pharmacology.
Murugaiah A. M. Subbaiah,
G. Schieven,
A. Mathur,
2024,
ACS medicinal chemistry letters.
G. Schieven,
A. Mathur,
D. Critton,
2024,
ACS medicinal chemistry letters.